Epigenetic modulation of microglial inflammatory gene loci in helminth-induced immune suppression: Implications for immune regulation in neurocysticercosis

ASN Neuro

Volumn 7, Issue 4, 2015, Pages 1-12

  Chauhan, Arun ^a   Quenum, Fredice Z ^a   Abbas, Ata ^a   Bradley, David S ^a   Nechaev, Sergei ^a   Singh, Brij B ^a   Sharma, Jyotika ^a   Mishra, Bibhuti B ^a  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Epigenetics; Helminth; Immune suppression; Microglia; Neurocysticercosis

Indexed keywords

ARGINASE 1; CD11B ANTIGEN; HELMINTH SOLUBLE FACTOR; HISTONE H3; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; NITRIC OXIDE; PARASITE ANTIGEN; RNA POLYMERASE II; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CIITA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; HISTONE; HLA ANTIGEN CLASS 2; MHC CLASS II TRANSACTIVATOR PROTEIN; NOS2 PROTEIN, MOUSE; NUCLEAR PROTEIN; POLYSACCHARIDE; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BRAIN TISSUE; CELL ACTIVATION; CELL MATURATION; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; EPIGENETICS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE LOCUS; HISTOPATHOLOGY; IMMUNE DEFICIENCY; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOREGULATION; IN VITRO STUDY; INFLAMMATION; MESOCESTOIDEA; MESOCESTOIDEA CORTI; MICROGLIA; MOUSE; NEUROCYSTICERCOSIS; NONHUMAN; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; C57BL MOUSE; CELL CULTURE; CENTRAL NERVOUS SYSTEM; DISEASE MODEL; DRUG EFFECTS; GENETIC EPIGENESIS; GENETICS; HELMINTH; HELMINTHIASIS; IMMUNOLOGY; METABOLISM; NEWBORN; PATHOGENICITY; PATHOLOGY;

ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM; CHROMATIN IMMUNOPRECIPITATION; CYTOKINES; DISEASE MODELS, ANIMAL; EPIGENESIS, GENETIC; HELMINTHIASIS; HELMINTHS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HISTONES; MICE; MICE, INBRED C57BL; MICROGLIA; NITRIC OXIDE SYNTHASE TYPE II; NUCLEAR PROTEINS; POLYSACCHARIDES; RNA POLYMERASE II; TRANS-ACTIVATORS;

EID: 84936989945     PISSN: None     EISSN: 17590914     Source Type: Journal    
DOI: 10.1177/1759091415592126     Document Type: Article

References (62)

1. Adalid-Peralta, L., Arce-Sillas, A., Fragoso, G., Cardenas, G., Rosetti, M., Casanova-Hernandez, D., . . . Sciutto, E. (2013). Cysticerci drive dendritic cells to promote in vitro and in vivo Tregs differentiation. Clinical & Developmental Immunology, 2013, 981468.
2. Adelman, K., Kennedy, M. A., Nechaev, S., Gilchrist, D. A., Muse, G. W., Chinenov, Y., . . . Rogatsky, I. (2009). Immediate mediators of the inflammatory response are poised for gene activation through RNA polymerase II stalling. Proceedings of the National Academy of Sciences of the United States of America, 106, 18207-18212.
3. Alvarez, J. I., Mishra, B. B., Gundra, U. M., Mishra, P. K., & Teale, J. M. (2010a). Mesocestoides corti intracranial infection as a murine model for neurocysticercosis. Parasitology, 137(3): 359-372.
4. Alvarez, J. I., Mishra, B. B., Gundra, U. M., Mishra, P. K., & Teale, J. M. (2010b). Mesocestoides corti intracranial infection as a murine model for neurocysticercosis. Parasitology, 137, 359-372.
5. Alvarez, J. I., Rivera, J., & Teale, J. M. (2008). Differential release and phagocytosis of tegument glycoconjugates in neurocysticercosis: Implications for immune evasion strategies. PLOS Neglected Tropical Diseases, 2, e218.
6. Alvarez, J. I., & Teale, J. M. (2007a). Differential changes in junctional complex proteins suggest the ependymal lining as the main source of leukocyte infiltration into ventricles in murine neurocysticercosis. Journal of Neuroimmunology, 187, 102-113.
7. Alvarez, J. I., & Teale, J. M. (2007b). Evidence for differential changes of junctional complex proteins in murine neurocysticercosis dependent upon CNS vasculature. Brain Research, 1169, 98-111.
8. Buecker, C., & Wysocka, J. (2012). Enhancers as information integration hubs in development: Lessons from genomics. Trends in Genetics: TIG, 28, 276-284.
9. Cardona, A. E., Gonzalez, P. A., & Teale, J. M. (2003). CC chemokines mediate leukocyte trafficking into the central nervous system during murine neurocysticercosis: Role of gamma delta T cells in amplification of the host immune response. Infection and Immunity, 71, 2634-2642.
10. Cardona, A. E., Restrepo, B. I., Jaramillo, J. M., & Teale, J. M. (1999). Development of an animal model for neurocysticercosis: Immune response in the central nervous system is characterized by a predominance of gamma delta T cells. Journal of Immunology, 162, 995-1002.
11. Cardona, A. E., & Teale, J. M. (2002). Gamma/delta T celldeficient mice exhibit reduced disease severity and decreased inflammatory response in the brain in murine neurocysticercosis. Journal of Immunology, 169, 3163-3171.
12. Chauhan, A., Sun, Y., Pani, B., Quenumzangbe, F., Sharma, J., Singh, B. B., . . . Mishra, B. B. (2014). Helminth induced suppression of macrophage activation is correlated with inhibition of calcium channel activity. PLoS One, 9, e101023.
13. Cherry, J. D., Olschowka, J. A., & O'Banion, M. K. (2014). Neuroinflammation and M2 microglia: The good, the bad, and the inflamed. Journal of Neuroinflammation, 11, 98.
14. De Santa, F., Narang, V., Yap, Z. H., Tusi, B. K., Burgold, T., Austenaa, L., . . . Natoli, G. (2009). Jmjd3 contributes to the control of gene expression in LPS-activated macrophages. The EMBO Journal, 28, 3341-3352.
15. Dhasarathy, A., Kajita, M., & Wade, P. A. (2007). The transcription factor snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor-alpha. Molecular Endocrinology, 21, 2907-2918.
16. Ernst, J., Kheradpour, P., Mikkelsen, T. S., Shoresh, N., Ward, L. D., Epstein, C. B., . . . Bernstein, B. E. (2011). Mapping and analysis of chromatin state dynamics in nine human cell types. Nature, 473, 43-49.
17. Escoubet-Lozach, L., Benner, C., Kaikkonen, M. U., Lozach, J., Heinz, S., Spann, N. J., . . . Glass, C. K. (2011). Mechanisms establishing TLR4-responsive activation states of inflammatory response genes. PLoS Genetics, 7, e1002401.
18. Fang, T. C., Schaefer, U., Mecklenbrauker, I., Stienen, A., Dewell, S., Chen, M. S., . . . Tarakhovsky, A. (2012). Histone H3 lysine 9 di-methylation as an epigenetic signature of the interferon response. Journal of Experimental Medicine, 209, 661-669.
19. Floden, A. M., Li, S., & Combs, C. K. (2005). Beta-amyloidstimulated microglia induce neuron death via synergistic stimulation of tumor necrosis factor alpha and NMDA receptors. The Journal of Neuroscience, 25, 2566-2575.
20. Frick, L. R., Williams, K., & Pittenger, C. (2013). Microglial dysregulation in psychiatric disease. Clinical & Developmental Immunology, 2013, 608654.
21. Garcia, H. H., & Del Brutto, O. H. (2005). Neurocysticercosis: Updated concepts about an old disease. The Lancet Neurology, 4, 653-661.
22. Gordon, S., & Martinez, F. O. (2010). Alternative activation of macrophages: Mechanism and functions. Immunity, 32, 593-604.
23. Gundra, U. M., Mishra, B. B., Wong, K., & Teale, J. M. (2011). Increased disease severity of parasite-infected TLR2-/-mice is correlated with decreased central nervous system inflammation and reduced numbers of cells with alternatively activated macrophage phenotypes in a murine model of neurocysticercosis. Infection and Immunity, 79, 2586-2596.
24. Hargreaves, D. C., Horng, T., & Medzhitov, R. (2009). Control of inducible gene expression by signal-dependent transcriptional elongation. Cell, 138, 129-145.
25. Harn, D. A., McDonald, J., Atochina, O., & Da'dara, A. A. (2009). Modulation of host immune responses by helminth glycans. Immunological Reviews, 230, 247-257.
26. Jenkins, S. J., & Allen, J. E. (2010). Similarity and diversity in macrophage activation by nematodes, trematodes, and cestodes. Journal of Biomedicine and Biotechnology, 2010, 262609.
27. Kielian, T. (2014). Neuroinflammation: Good, bad, or indifferent? Journal of Neurochemistry, 130, 1-3.
28. Kobayashi, K., Imagama, S., Ohgomori, T., Hirano, K., Uchimura, K., Sakamoto, K., . . . Kadomatsu, K. (2013). Minocycline selectively inhibits M1 polarization of microglia. Cell Death & Disease, 4, e525.
29. Kreider, T., Anthony, R. M., Urban, J. F., & Gause, W. C. Jr. (2007). Alternatively activated macrophages in helminth infections. Current Opinion in Immunology, 19, 448-453.
30. Kruidenier, L., Chung, C. W., Cheng, Z., Liddle, J., Che, K., Joberty, G., . . . Wilson, D. M. (2012). A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response. Nature, 488, 404-408.
31. Latchman, Y., Wood, C. R., Chernova, T., Chaudhary, D., Borde, M., Chernova, I., . . . Freeman, G. J. (2001). PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nature Immunology, 2, 261-268.
32. Lawrence, T., & Natoli, G. (2011). Transcriptional regulation of macrophage polarization: Enabling diversity with identity. Nature Reviews Immunology, 11, 750-761.
33. Leng, J., Butcher, B. A., Egan, C. E., Abi Abdallah, D. S., & Denkers, E. Y. (2009). Toxoplasma gondii prevents chromatin remodeling initiated by TLR-triggered macrophage activation. Journal of Immunology, 182, 489-497.
34. Medzhitov, R., & Horng, T. (2009). Transcriptional control of the inflammatory response. Nature Reviews Immunology, 9, 692-703.
35. Mishra, B. B., Gundra, U. M., & Teale, J. M. (2008). Expression and distribution of Toll-like receptors 11-13 in the brain during murine neurocysticercosis. Journal of Neuroinflammation, 5, 53.
36. Mishra, B. B., Gundra, U. M., & Teale, J. M. (2009a). Toll-like receptors in CNS parasitic infections. Current Topics in Microbiology and Immunology, 336, 83-104.
37. Mishra, B. B., Gundra, U. M., & Teale, J. M. (2010). STAT6(-/-) mice exhibit decreased cells with alternatively activated macrophage phenotypes and enhanced disease severity in murine neurocysticercosis. Journal of Neuroimmunology, 232(1-2): 26-34.
38. Mishra, B. B., Gundra, U. M., Wong, K., & Teale, J. M. (2009b). MyD88-deficient mice exhibit decreased parasite-induced immune responses but reduced disease severity in a murine model of neurocysticercosis. Infection and Immunity, 77, 5369-5379.
39. Mishra, B. B., Mishra, P. K., & Teale, J. M. (2006). Expression and distribution of Toll-like receptors in the brain during murine neurocysticercosis. Journal of Neuroimmunology, 181, 46-56.
40. Mosser, D. M., & Edwards, J. P. (2008). Exploring the full spectrum of macrophage activation. Nature Reviews Immunology, 8, 958-969.
41. Murray, P. J., & Wynn, T. A. (2011). Protective and pathogenic functions of macrophage subsets. Nature Reviews Immunology, 11, 723-737.
42. Nagamoto-Combs, K., & Combs, C. K. (2010). Microglial phenotype is regulated by activity of the transcription factor, NFAT (nuclear factor of activated T cells). The Journal of Neuroscience, 30, 9641-9646.
43. Nash, T. E., Singh, G., White, A. C., Rajshekhar, V., Loeb, J. A., Proano, J. V., . . . Garcia, H. H. (2006). Treatment of neurocysticercosis: Current status and future research needs. Neurology, 67, 1120-1127.
44. Natoli, G., Ghisletti, S., & Barozzi, I. (2011). The genomic landscapes of inflammation. Genes & Development, 25, 101-106.
45. Nayak, D., Zinselmeyer, B. H., Corps, K. N., & McGavern, D. B. (2012). In vivo dynamics of innate immune sentinels in the CNS. Intravital, 1, 95-106.
46. Ramesh, G., MacLean, A. G., & Philipp, M. T. (2013a). Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain. Mediators of Inflammation, 2013, 480739.
47. Ramesh, G., Philipp, M. T., Vallieres, L., MacLean, A. G., & Ahmad, M. (2013b). Mediators of neuroinflammation. Mediators of Inflammation, 2013, 314261.
48. Restrepo, B. I., Alvarez, J. I., Castano, J. A., Arias, L. F., Restrepo, M., Trujillo, J., . . . Teale, J. M. (2001). Brain granulomas in neurocysticercosis patients are associated with a Th1 and Th2 profile. Infection and Immunity, 69, 4554-4560.
49. Rivest, S. (2009). Regulation of innate immune responses in the brain. Nature Reviews Immunology, 9, 429-439.
50. Rogatsky, I., & Adelman, K. (2014). Preparing the first responders: Building the inflammatory transcriptome from the ground up. Molecular Cell, 54, 245-254.
51. Roman, G., Sotelo, J., Del Brutto, O., Flisser, A., Dumas, M., Wadia, N., . . . Spina-Franca, A. (2000). A proposal to declare neurocysticercosis an international reportable disease. Bulletin of the World Health Organization, 78, 399-406.
52. Sangiuliano, B., Perez, N. M., Moreira, D. F., & Belizario, J. E. (2014). Cell death-associated molecular-pattern molecules: Inflammatory signaling and control. Mediators of Inflammation, 2014, 821043.
53. Sciutto, E., Chavarria, A., Fragoso, G., Fleury, A., & Larralde, C. (2007). The immune response in Taenia solium cysticercosis: Protection and injury. Parasite Immunology, 29, 621-636.
54. Sharpe, A. H., Wherry, E. J., Ahmed, R., & Freeman, G. J. (2007). The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nature Immunology, 8, 239-245.
55. Smale, S. T. (2010). Selective transcription in response to an inflammatory stimulus. Cell, 140, 833-844.
56. Sun, Y., Chauhan, A., Sukumaran, P., Sharma, J., Singh, B. B., Mishra, B. B. (2014). Inhibition of store-operated calcium entry in microglia by helminth factors: Implications for immune suppression in neurocysticercosis. Journal of Neuroinflammation, 11, 1.
57. Takeuchi, O., & Akira, S. (2010). Pattern recognition receptors and inflammation. Cell, 140, 805-820.
58. White, A. C. Jr. (1997). Neurocysticercosis: A major cause of neurological disease worldwide. Clinical Infectious Diseases, 24, 101-113; quiz 114-105.
59. White, A. C. Jr. (2000). Neurocysticercosis: Updates on epidemiology, pathogenesis, diagnosis, and management. Annual Review of Medicine, 51, 187-206.
60. White, A. C., Robinson, P., & Kuhn, R. (1997). Taenia solium cysticercosis: Host-parasite interactions and the immune response. Chemical Immunology, 66, 209-230.
61. Zhou, V. W., Goren, A., & Bernstein, B. E. (2011). Charting histone modifications and the functional organization of mammalian genomes. Nature Reviews Genetics, 12, 7-18.
62. Zhu, Y., van Essen, D., & Saccani, S. (2012). Cell-type-specific control of enhancer activity by H3K9 trimethylation. Molecular Cell, 46, 408-423.